Meso Numismatics Inc (MSSV)
0.036
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Meso Numismatics Cash from Operations (TTM): -0.4192M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.4192M |
September 30, 2023 | -0.4392M |
June 30, 2023 | -0.6015M |
March 31, 2023 | -0.5913M |
December 31, 2022 | -1.114M |
September 30, 2022 | -9.814M |
June 30, 2022 | -10.09M |
March 31, 2022 | -10.24M |
December 31, 2021 | -9.879M |
September 30, 2021 | -1.227M |
June 30, 2021 | -0.8882M |
Date | Value |
---|---|
March 31, 2021 | -0.4129M |
December 31, 2020 | -0.3227M |
September 30, 2020 | -0.2743M |
June 30, 2020 | -0.3168M |
March 31, 2020 | -0.3344M |
December 31, 2019 | -0.3623M |
September 30, 2019 | -0.3877M |
June 30, 2019 | -0.3213M |
March 31, 2019 | -0.3023M |
December 31, 2018 | -0.2446M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-10.24M
Minimum
Mar 2022
-0.2743M
Maximum
Sep 2020
-2.528M
Average
-0.4392M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
CEL-SCI Corp | -23.07M |
AIM ImmunoTech Inc | -21.27M |
IGC Pharma Inc | -6.19M |
NovaBay Pharmaceuticals Inc | -4.131M |
Protalix BioTherapeutics Inc | -1.318M |